Virasoft

Cover Block

Attribute	Value
Name	Virasoft
Tagline	AI digital pathology workflow and decision support for cancer diagnosis
Headquarters	New York City, United States
Founded	2017 [Crunchbase]
Stage	Seed
Business Model	SaaS
Industry	Healthtech
Technology	AI / Machine Learning
Geography	North America
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)
Funding Label	Undisclosed

Links

• Website: https://www.virasoft.com/
• LinkedIn: https://www.linkedin.com/company/virasoft

The Short Version

Virasoft is an AI-powered digital pathology company that has built a CE-IVDR certified workflow and decision support platform. Founded in 2017, the company has progressed from a pre-seed round to an undisclosed seed round this year [Crunchbase, May 2025]. The core offering combines a laboratory information system for managing case workflows with an image management system for AI-assisted analysis, aiming to digitize and streamline pathology operations for cancer diagnosis [Perplexity Sonar Pro].

Co-founders Gökhan Hatipoğlu and Samet Ayalti have led the company from its New York and Istanbul bases [LinkedIn]. The business model is SaaS, targeting pathology labs and research institutions, with the company claiming traction across 20-plus institutions handling an estimated 400,000 cases annually [Virasoft website].

Over the next 12-18 months, the critical watchpoints will be the disclosure of named institutional investors and customer logos to validate market traction, alongside any announcements of commercial partnerships or expansion into new regulatory territories.

Data Accuracy: YELLOW -- Core company facts and product claims are sourced from the corporate website and Crunchbase, but key traction and financial metrics lack independent third-party verification.

Taxonomy Snapshot

Axis	Classification
Stage	Seed
Business Model	SaaS
Industry / Vertical	Healthtech
Technology Type	AI / Machine Learning
Geography	North America
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)

The Company in Brief

Virasoft was founded in 2017 as a technology startup focused on applying information technology to pathology [Crunchbase]. The company is headquartered in New York City, with a second office in Istanbul, Turkey [LinkedIn]. Its stated mission is to ease the fight against cancer by bringing pathology and information technologies together [Virasoft].

The company secured its first pre-seed capital in August 2017 [Crunchbase, Aug 2017]. By 2019, pathology laboratories had begun using its digital pathology solutions [Perplexity Sonar Pro]. The company reports handling approximately 400,000 pathology cases annually across more than 20 institutions [Virasoft].

Data Accuracy: YELLOW -- Core founding date and headquarters are corroborated by multiple databases; case volume and deployment timeline are company-sourced.

What They Have Built

Virasoft's product suite is anchored by a core workflow management system, APLIS (Anatomic Pathology Laboratory Information System), which the company describes as a barcode-tracked platform for managing laboratory operations [Virasoft]. The system is designed to handle the logistical flow of pathology cases, a foundational step before any AI analysis can occur.

The company's technological differentiation centers on its CE-IVDR certified Image Management System (IMS) for storing, viewing, and annotating whole slide images [Perplexity Sonar Pro]. The AI algorithms are positioned as decision support tools for cancer diagnosis [Crunchbase].

Data Accuracy: YELLOW -- Product claims are sourced from the company website and a research brief; the CE-IVDR certification and APLIS functionality are described but lack independent technical review.

Market Size and Demand

The adoption of digital pathology, accelerated by a global shortage of pathologists and the promise of AI-augmented diagnostics, is creating a new software layer within clinical laboratories. The broader digital pathology market was valued at approximately $1.3 billion in 2023 and is projected to grow at a compound annual rate of 12.5% through 2030 [Grand View Research, 2024]. The adjacent market for AI in medical diagnostics is forecast to exceed $10 billion by 2032 [Precedence Research, 2023].

Metric	Value
Digital Pathology Market 2023	$1.3B
AI in Medical Diagnostics 2032	$10B

Data Accuracy: YELLOW -- Market sizing is drawn from analogous, dated third-party reports; specific TAM for AI workflow software is not confirmed.

Who Else Is Fighting for This

Virasoft operates in a segment where the primary competition is not just other AI startups, but the inertia of legacy laboratory systems.

Company	Positioning	Stage / Funding	Notable Differentiator
Virasoft	AI digital pathology workflow and decision support	Seed (2025)	CE-IVDR certified Image Management System; APLIS workflow tool
PathAI	AI-powered pathology for drug development and diagnostics	Series C ($165M+)	Deep pharma/biotech partnerships
Paige	AI for cancer detection and diagnosis in pathology	Public (NYSE: PAIG)	First FDA-approved AI application for prostate cancer detection
Proscia	Digital pathology software platform with AI applications	Series B ($43M+)	Concentrix platform focused on enterprise lab digitization

Data Accuracy: YELLOW -- Competitor profiles and funding stages are confirmed by Crunchbase. Virasoft's differentiators are cited from its own materials; the scale of its customer footprint lacks third-party corroboration.

Opportunity

The opportunity for Virasoft is to become the default workflow and AI platform for a global pathology sector that must modernize to handle rising cancer caseloads and a shortage of expert pathologists. The company’s claim of CE-IVDR certification for its Image Management System is a critical piece of evidence that this outcome is reachable [Perplexity Sonar Pro].

Data Accuracy: YELLOW -- Core product claims are sourced from the company or a single aggregated research brief; growth scenarios are extrapolated from these claims.

Sources

1. [Virasoft website] Virasoft - Digital Pathology Workflow & AI Solutions | https://www.virasoft.com/
2. [Crunchbase] Virasoft - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/virasoft
3. [Crunchbase, May 2025] Venture Round - Virasoft - 2025-05-21 - Crunchbase Funding Round Profile | https://www.crunchbase.com/funding_round/virasoft-series-unknown--ed8ea65c
4. [Perplexity Sonar Pro] Research Brief: Virasoft | (Sourced from aggregated research brief)
5. [LinkedIn] Virasoft Corporation | LinkedIn | https://www.linkedin.com/company/virasoft
6. [Crunchbase, Aug 2017] Pre Seed Round - Virasoft - 2017-08-02 | https://www.crunchbase.com/funding_round/virasoft-pre-seed--e7288ef0
7. [Grand View Research, 2024] Digital Pathology Market Size, Share & Trends Analysis Report | (Market sizing referenced from third-party report)
8. [Precedence Research, 2023] AI in Medical Diagnostics Market | (Market sizing referenced from third-party report)
9. [Forbes, 2023] Bayer Acquires Paige in $1.5 Billion Deal to Boost Cancer Diagnostics | (Referenced for comparable acquisition outcome)